Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGarrido, Pilar
dc.contributor.authorAdjei, A. A.
dc.contributor.authorBajpai, J.
dc.contributor.authorBerghoff, A. S.
dc.contributor.authorChoo, S. P.
dc.contributor.authorFelip Font, Enriqueta
dc.contributor.authorGarralda Cabanas, Elena
dc.contributor.authorTabernero Caturla, Josep
dc.contributor.authorBanerjee, Susana
dc.date.accessioned2022-02-23T06:49:57Z
dc.date.available2022-02-23T06:49:57Z
dc.date.issued2021-06
dc.identifier.citationGarrido P, Adjei AA, Bajpai J, Banerjee S, Berghoff AS, Choo SP, et al. Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey. ESMO Open. 2021 Jun;6(3):100131.
dc.identifier.issn2059-7029
dc.identifier.urihttps://hdl.handle.net/11351/7072
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Desigualtats; Dona
dc.description.sponsorshipThis work was supported by the European Society for Medical Oncology (ESMO).
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesESMO Open;6(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPandèmia de COVID-19, 2020-
dc.subjectOncologia
dc.subjectQüestionaris
dc.subject.meshCoronavirus Infections
dc.subject.meshOncologists
dc.subject.meshSurveys and Questionnaires
dc.titleHas COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.esmoop.2021.100131
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsoncólogos
dc.subject.decsencuestas y cuestionarios
dc.relation.publishversionhttps://doi.org/10.1016/j.esmoop.2021.100131
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Garrido P] Universidad de Alcalá, Medical Oncology Department, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Adjei AA] Mayo Clinic, Rochester, USA. [Bajpai J] Tata Memorial Centre, Mumbai, India. [Banerjee S] The Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK. [Berghoff AS] Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria. [Choo SP] Curie Oncology Singapore, National Cancer Centre Singapore, Singapore. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Thoracic Oncology and H&N Cancer Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain. [Garralda E] Early Drug Development Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain
dc.identifier.pmid34144778
dc.identifier.wos000663044500027
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple